M

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Watchlist Manager
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Watchlist
Price: 121.2 SAR 1.68% Market Closed
Market Cap: 2.4B SAR
Have any thoughts about
Middle East Pharmaceutical Industries Company SJSC?
Write Note

Income Statement

Earnings Waterfall
Middle East Pharmaceutical Industries Company SJSC

Revenue
596.5m SAR
Cost of Revenue
-231.5m SAR
Gross Profit
364.9m SAR
Operating Expenses
-242.9m SAR
Operating Income
122m SAR
Other Expenses
-21.2m SAR
Net Income
100.9m SAR

Income Statement
Middle East Pharmaceutical Industries Company SJSC

Rotate your device to view
Income Statement
Currency: SAR
Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
338
N/A
508
+50%
515
+2%
596
+16%
Gross Profit
Cost of Revenue
(131)
(201)
(197)
(232)
Gross Profit
207
N/A
306
+48%
318
+4%
365
+15%
Operating Income
Operating Expenses
(129)
(195)
(203)
(243)
Selling, General & Administrative
(121)
(183)
(190)
(228)
Depreciation & Amortization
(8)
(12)
(12)
(15)
Other Operating Expenses
(0)
(1)
(1)
(0)
Operating Income
78
N/A
111
+42%
115
+3%
122
+6%
Pre-Tax Income
Interest Income Expense
(6)
(8)
(8)
(8)
Total Other Income
(1)
(2)
(2)
(2)
Pre-Tax Income
71
N/A
102
+43%
106
+4%
111
+5%
Net Income
Tax Provision
(6)
(9)
(9)
(10)
Income from Continuing Operations
66
93
97
101
Net Income (Common)
66
N/A
93
+42%
97
+4%
101
+4%
EPS (Diluted)
3.29
N/A
4.66
+42%
4.85
+4%
5.04
+4%

See Also

Discover More